Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics

NCT02239666 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02239666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02239666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 1, 2014
Completion date
January 5, 2017
Enrollment
899 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis